Conformational antigenic heterogeneity as a cause of the persistent fraction in HIV-1 neutralization

Mostrar otras versiones (1)

BACKGROUND: Neutralizing antibodies (NAbs) protect against HIV-1 acquisition in animal models and show promise in treatment of infection. They act by binding to the viral envelope glycoprotein (Env), thereby blocking its receptor interactions and fusogenic function. The potency of neutralization is...

Descripción completa

Detalles Bibliográficos
Autores principales: Colin, Philippe, Ringe, Rajesh P., Yasmeen, Anila, Ozorowski, Gabriel, Ketas, Thomas J., Lee, Wen-Hsin, Ward, Andrew B., Moore, John P., Klasse, P.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980222/
https://www.ncbi.nlm.nih.gov/pubmed/36865101
http://dx.doi.org/10.21203/rs.3.rs-2613503/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980222/
https://www.ncbi.nlm.nih.gov/pubmed/36865101
http://dx.doi.org/10.21203/rs.3.rs-2613503/v1

Ejemplares similares